DPBIO Inc

Through groundbreaking technology, we are revolutionizing life sciences at DPBIO by harnessing the power of high-throughput droplet microfluidics. As a pioneering innovator, we are dedicated to developing comprehensive solutions that integrate advanced microfluidic technology with biological applications, empowering researchers and industry leaders worldwide to push the boundaries of scientific discovery.

Our flagship platforms, including the CytoSpark® High-throughput Screening System and the OMNIdrop System, represent a significant leap forward in precision medicine and biotechnology. By enabling the encapsulation, detection, and screening of millions of single cells in a single run, we are drastically accelerating workflows in antibody discovery, enzyme evolution, and cancer research. Our technology not only exceeds traditional screening throughput but also unlocks new possibilities for identifying functional cells with exceptional specificity and affinity. At DPBIO, we are committed to driving the future of biomedical research, providing scientists with the tools they need to tackle complex therapeutic targets and accelerate the development of life-saving treatments.